MARC Record from marc_columbia

LEADER: 03981pam a22003854a 4500
001 4860255
005 20221109191825.0
008 021017t20032003nyu 001 0 eng
010 $a 2002038769
016 7 $a101184193$2DNLM
020 $a0060010304 (alk. paper)
035 $a(OCoLC)ocm50859163
035 $a(NNC)4860255
035 $a4860255
040 $aDLC$cDLC$dYDX$dNLM$dOrLoB-B
042 $apcc
050 00 $aRC271.I43$bV375 2003
060 00 $a2003 I-359
060 10 $aQZ 267$bV332m 2003
082 00 $a616.99/4061$221
100 1 $aVasella, Daniel.$0http://id.loc.gov/authorities/names/n2002162573
245 10 $aMagic cancer bullet :$bhow a tiny orange pill is rewriting medical history /$cDaniel Vasella, with Robert Slater.
260 $aNew York :$bHarperBusiness,$c[2003], ©2003.
300 $aviii, 258 pages ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aIncludes index.
505 00 $tThe Dreaded Word -- $tForeword: Patient Tales -- $tIntroduction -- $tMolecules and Pathways -- $g1.$tIt's in Our Genes! -- $g2.$tOn the Shoulders of Giants -- $g3.$tThe Diamond -- $tPatients and Doctors - The Awakening -- $g4.$tThe Moment of Truth -- $g5.$tThe Petition -- $tManaging Gleevec -- $g6.$tVictory in May: A Record-Breaking Approval -- $g7.$tSuccess Management: Giving Credit Where Credit Is Due -- $tAnita Scherzer: The GIST Patient -- $tRichard Rockefeller: The Doctor Patient -- $tSuzan McNamara: Completing Her Story -- $tDarlene Vaughan: The Miracle Patient -- $tMarco Nese: Buying That Dog -- $tJudy Orem: Breakfast, Then Six Pills.
520 1 $a"When the first results from patient trials appeared on Dr. Daniel Vasella's desk in April 1999, the chairman and CEO of Novartis sensed that an important chapter of medical history was about to be rewritten. The results indicated that Gleevac, the tiny orange capsule - the development of which he had spearheaded - was working wonders to arrest a life-threatening form of blood cancer. Here, for the first time, Dr. Vasella recounts the step-by-step challenges of bringing this revolutionary medicine to market and producing it in large enough quantities to make a difference in the lives of patients and their families everywhere in the world." "The leaders of major pharmaceutical companies rarely speak out so candidly and comprehensively about their businesses, but in this book Dr. Vasella takes us behind the scenes and reveals the enormous pressures, the heavy costs, and the high risks involved in betting heavily on a drug like Gleevac - regarded by many as the most exciting cancer breakthrough discovery yet - while staying focused on the ultimate goal of saving lives." "Magic Cancer Bullet is the first authoritative account of how Gleevac was developed and produced; of how on May 10, 2001 it won the swiftest passage from the Food and Drug Administration ever for a cancer drug; of how, even now, it is changing the lives and outlooks of patients everywhere, bringing hope in bleak and dire circumstances. From his unique vantage point as the man who guided this lifesaving "magic cancer bullet" from the laboratory to the pharmacy, Dr. Daniel Vasella gives us an insider's account of the scientists, the Novartis executives, and the Gleevec patients on this remarkable journey and he shows why the story of Gleevec is an intriguing part of the search for a cure to the scourge of cancer, one of the greatest human afflications of our time."--BOOK JACKET.
650 0 $aImatinib.$0http://id.loc.gov/authorities/subjects/sh2002008739
650 12 $aNeoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009369Q000188
650 12 $aPiperazines$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D010879Q000627
700 1 $aSlater, Robert,$d1943-2014.$0http://id.loc.gov/authorities/names/n81010793
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/description/hc042/2002038769.html
852 00 $boff,hsl$hRC271.I43$iV375 2003